SACUMADA 50MG 14S

About

Sacumada 50mg contains Sacubitril/Valsartan, an angiotensin receptor-neprilysin inhibitor (ARNI), a novel medication primarily used for the treatment of chronic heart failure with reduced ejection fraction. This combination drug works through two complementary mechanisms: Valsartan, an angiotensin receptor blocker, inhibits the harmful effects of angiotensin II, leading to vasodilation and reduced fluid retention. Sacubitril, a neprilysin inhibitor, prevents the breakdown of natriuretic peptides, which are beneficial hormones that promote vasodilation, natriuresis, and diuresis, thereby reducing cardiac workload and improving cardiac function. This dual action significantly reduces the risk of cardiovascular death and heart failure hospitalization, offering a substantial improvement in outcomes for eligible patients. It represents a significant advancement in the management of heart failure.

Uses

• Treatment of chronic heart failure with reduced ejection fraction.
• Reduction of cardiovascular death and heart failure hospitalization.
• Improvement of symptoms and physical limitations in heart failure.
• Management of symptomatic chronic heart failure.

Directions For Use

Take this medication orally, usually twice daily, with or without food, as directed by your doctor. Do not take with ACE inhibitors.

Benefits

• Significantly reduces heart failure hospitalizations.
• Lowers risk of cardiovascular death.
• Improves heart function and symptoms.
• Novel dual mechanism of action.
• Enhances quality of life for heart failure patients.
• Provides comprehensive heart failure management.

Side Effects

• Hypotension (low blood pressure)
• Hyperkalemia (high potassium)
• Cough
• Dizziness
• Renal impairment
• Fatigue
• Nausea
• Diarrhea
• Angioedema (rare but serious)
• Anemia
• Back pain
• Syncope (fainting)

Safety Measures

• Alcohol - Alcohol can increase the hypotensive effect and risk of dizziness. It is advisable to limit or avoid alcohol consumption.
• Pregnancy - Contraindicated during pregnancy due to significant risk of fetal injury or death, especially in the second and third trimesters.
• Breastfeeding - Not recommended during breastfeeding as it is unknown if components pass into breast milk and potential for serious adverse effects on the infant.
• Liver - Use with caution in patients with moderate hepatic impairment; not recommended in severe hepatic impairment.
• Kidney - Use with caution in patients with renal impairment; dosage adjustments may be necessary. Monitor kidney function closely.
• Lung - Generally safe for lung conditions, but monitor for cough, which is a known side effect, though less common than with ACE inhibitors.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.